BioCMC Consult ApS: Financial statements 2022
CVR: 37197475
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
BioCMC Consult ApS (CVR 37197475) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK 0 compared with DKK -30,016 the year before. Equity in the 2022 report amounted to DKK 90. The solvency ratio was 100%.
- Profit/Loss
- DKK 0
- Equity
- DKK 90
- Total Assets
- DKK 90
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | 0 | 90 | - |
| 2021 | - | -25 t. | -30 t. | 3 t. | - |
| 2020 | - | 113 t. | 83 t. | 260 t. | - |
| 2019 | 207 t. | 141 t. | 100 t. | 126 t. | - |
| 2018 | 194 t. | 172 t. | -27 t. | 26 t. | - |
Official annual report
Keep an eye on BioCMC Consult ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BioCMC Consult ApS has published its annual report for 2021. Gross profit came to DKK -25,309, and the net result was DKK -30,016.
About BioCMC Consult ApS
BioCMC Consult ApS was a Danish company of the type Anpartsselskab based in Roskilde, founded in 2015. The company has been dissolved on 17 October 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee (2017). In 2022, the company reported a net result of DKK 0 compared with DKK -30,016 the year before. Equity in the 2022 report amounted to DKK 90.